0000950170-23-048422.txt : 20230915 0000950170-23-048422.hdr.sgml : 20230915 20230915171735 ACCESSION NUMBER: 0000950170-23-048422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230915 DATE AS OF CHANGE: 20230915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adjuvant Global Health Technology Fund, L.P. CENTRAL INDEX KEY: 0001783165 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 231259490 BUSINESS ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adjuvant Global Health Technology Fund DE, L.P. CENTRAL INDEX KEY: 0001799812 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 231259489 BUSINESS ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adjuvant Capital GP, L.P. CENTRAL INDEX KEY: 0001935100 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 231259488 BUSINESS ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adjuvant Capital Management, LLC CENTRAL INDEX KEY: 0001935084 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 231259487 BUSINESS ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AN2 Therapeutics, Inc. CENTRAL INDEX KEY: 0001880438 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820606654 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 EL CAMINO REAL, SUITE D CITY: MENLO PARK STATE: CA ZIP: 94027 BUSINESS PHONE: (650) 331-9090 MAIL ADDRESS: STREET 1: 1800 EL CAMINO REAL, SUITE D CITY: MENLO PARK STATE: CA ZIP: 94027 4 1 ownership.xml 4 X0508 4 2023-08-23 0001880438 AN2 Therapeutics, Inc. ANTX 0001783165 Adjuvant Global Health Technology Fund, L.P. C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 false false true false 0001799812 Adjuvant Global Health Technology Fund DE, L.P. C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 false false true false 0001935100 Adjuvant Capital GP, L.P. C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 false false true false 0001935084 Adjuvant Capital Management, LLC C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 false false true false false Common Stock 2023-09-13 4 S false 336 16.00 D 2177547 D Common Stock 2023-09-13 4 S false 64 16.00 D 411893 I By Adjuvant Global Health Technology Fund DE, L.P.( The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022. Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. Adjuvant Global Health Technology Fund, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz 2023-09-15 Adjuvant Global Health Technology Fund DE, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz 2023-09-15 Adjuvant Capital GP, L.P., By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz 2023-09-15 Adjuvant Capital Management, L.L.C., By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz 2023-09-15